AbbVie Aktie
170,80
EUR
-1,55
EUR
-0,90
%
201,26
USD
-0,22
USD
-0,11
%
nachbörslich
Werbung
AbbVie Aktie Analyse
| 29.04.19 | AbbVie Market Perform | BMO Capital Markets | |
| 26.12.18 | AbbVie Buy | Standpoint Research | |
| 23.10.15 | AbbVie Buy | UBS AG | |
| 17.04.15 | AbbVie Outperform | BMO Capital Markets | |
| 06.01.15 | AbbVie Buy | UBS AG | |
| 26.11.14 | AbbVie Buy | Argus Research Company | |
| 14.11.14 | AbbVie Buy | Deutsche Bank AG |
Werbung
Werbung